Heart failure was obtained from Heart Failure Molecular Epidemiology for Therapeutic Targets (HERMES) consortium, with 47,309 cases and 930,014 controls [27]
The interaction between GLP-1 medications, other diabetes drugs, and dietary factors creates a complex optimization problem that benefits from specialist oversight
For individuals who previously relied on eating to regulate their emotions, this shift may lead to difficulties in emotional adaptation
The absence of visible changes does not guarantee medication integrity after freezing exposure
Tirzepatide was initially approved for type 2 diabetes (Mounjaro), and it is now also approved for long-term weight loss in adults with obesity or overweight with weight-related health conditions (Zepbound)
Interventions for enhancing medication adherence